Glenmark Pharmaceuticals Limited (BOM:532296)
India · Delayed Price · Currency is INR 2,233.30
+42.25 (1.93%)
At close: Jul 31, 2026
Glenmark Pharmaceuticals Market Cap
Glenmark Pharmaceuticals has a market cap or net worth of 630.41 billion as of July 31, 2026. Its market cap has increased by 3.73% in one year.
Market Cap
630.41B
Enterprise Value
624.58B
Revenue
177.37B
Ranking
n/a
PE Ratio
35.06
Stock Price
2,233.30
ChartMarket Cap Chart
Since June 7, 2001, Glenmark Pharmaceuticals's market cap has increased from 1.15B to 630.41B, an increase of 54,751.35%. That is a compound annual growth rate of 28.48%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 630.41B | 9.76% |
| Dec 31, 2025 | 574.34B | 26.49% |
| Dec 31, 2024 | 454.07B | 88.44% |
| Dec 29, 2023 | 240.96B | 101.33% |
| Dec 30, 2022 | 119.68B | -19.75% |
| Dec 31, 2021 | 149.14B | 7.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Torrent Pharmaceuticals | 1.85T |
| Lupin | 1.11T |
| Dr. Reddy's Laboratories | 953.23B |
| Abbott India | 585.76B |
| GlaxoSmithKline Pharmaceuticals | 442.09B |
| J. B. Chemicals & Pharmaceuticals | 387.31B |
| Rubicon Research | 247.16B |
| Granules India | 206.66B |